KBC Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44K Buy
+555
New +$54K ﹤0.01% 1747
2025
Q2
– Sell
-648
Closed -$70K – 1716
2025
Q1
$70K Buy
+648
New +$56.4K ﹤0.01% 1672
2024
Q4
– Sell
-385
Closed -$38K – 1833
2024
Q3
$38K Hold
385
– – ﹤0.01% 1794
2024
Q2
$63K Hold
385
– – ﹤0.01% 1471
2024
Q1
$59K Buy
385
+132
+52% +$22K ﹤0.01% 1449
2023
Q4
$79K Hold
253
– – ﹤0.01% 1208
2023
Q3
$112K Buy
+253
New +$114K ﹤0.01% 966

Other funds holding AGL

KBC Group's AGL Position: Q3 2026 in Review

KBC Group opened a new position in Agilon Health (AGL) in Q3 2026: 555 shares worth $44K. The stake represents ﹤0.01% of the portfolio and ranks #1747 among its holdings. This is a return to the name: KBC Group previously reported a position in AGL as recently as Q1 2025.

KBC Group first reported a position in AGL in Q3 2023 and has held it in 7 quarters since. The position peaked at $112K in Q3 2023. 63 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • KBC Group held 555 shares of Agilon Health worth $44K as of Q3 2026.
  • Agilon Health was a new KBC Group position in Q3 2026.
  • Agilon Health made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1747 holding.
  • KBC Group first reported a position in Agilon Health in Q3 2023 and has held it in 7 quarters since.
  • KBC Group's Agilon Health position peaked at $112K in Q3 2023.
  • 63 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.